Alector Inc
ALEC·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$2.23
Today
+23.2%
YTD
+17.5%
About
Established in 2013, Alector Inc is a clinical stage biopharmaceutical company developing treatments for neurodegeneration diseases. Operating within the US, Alector has its headquarters in South San Francisco, California. The company is listed using the ALEC ticker on the NASDAQ GS. Add ALEC stock to your eToro watchlist to obtain the latest price updates.
Price chart
Closing price history for ALEC (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-1.66
P/S (TTM)14.52
P/B (TTM)-20.27
Market cap$202.10M
Cap tierMicro-cap
Industry avg P/E-1.99
Profitability
Gross margin37.07%
EBIT margin-856.86%
Net margin-692.47%
ROE-385.11%
ROA-42.15%
Earnings & Revenue
Revenue (TTM)$13.86M
Revenue growth (1Y)-82.9%
EPS (TTM)-$1.09
Free cash flow$-158.39M
Total debt$32.76M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.77
Employees103
Next earnings5 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.